Technical Analysis for HVO - Hvivo Plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 26.77 | -1.76% | -0.48 |
Earnings due: Apr 23
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Centerline Cross | Bearish | -1.76% | |
NR7 | Range Contraction | -1.76% | |
Lower Bollinger Band Walk | Weakness | -1.76% | |
Inside Day | Range Contraction | -1.76% | |
Below Lower BB | Weakness | -1.76% | |
Lower Bollinger Band Touch | Weakness | -1.76% | |
Oversold Stochastic | Weakness | -1.76% | |
Lower Bollinger Band Walk | Weakness | -3.00% | |
Below Lower BB | Weakness | -3.00% | |
Lower Bollinger Band Touch | Weakness | -3.00% |
Alert | Time |
---|---|
Down 1 ATR | about 3 hours ago |
Fell Below Previous Day's Low | about 4 hours ago |
Down 3% | about 4 hours ago |
Down 2% | about 4 hours ago |
Down 1% | about 4 hours ago |
Get a Trading Assistant
Hvivo Plc Description
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides preclinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Manufacturing Disease Data Management Drug Development Infectious Disease Biomarker Asthma Malaria Cell Biology Copd
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 31.9977 |
52 Week Low | 13.999 |
Average Volume | 3,465,319 |
200-Day Moving Average | 22.24 |
50-Day Moving Average | 27.98 |
20-Day Moving Average | 28.88 |
10-Day Moving Average | 28.53 |
Average True Range | 1.15 |
RSI (14) | 41.18 |
ADX | 25.2 |
+DI | 12.71 |
-DI | 17.09 |
Chandelier Exit (Long, 3 ATRs) | 28.54 |
Chandelier Exit (Short, 3 ATRs) | 30.45 |
Upper Bollinger Bands | 30.41 |
Lower Bollinger Band | 27.35 |
Percent B (%b) | -0.03 |
BandWidth | 10.59 |
MACD Line | -0.06 |
MACD Signal Line | 0.26 |
MACD Histogram | -0.3157 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 28.15 | ||||
Resistance 3 (R3) | 28.17 | 27.88 | 28.00 | ||
Resistance 2 (R2) | 27.88 | 27.65 | 27.88 | 27.95 | |
Resistance 1 (R1) | 27.57 | 27.51 | 27.43 | 27.55 | 27.90 |
Pivot Point | 27.28 | 27.28 | 27.21 | 27.28 | 27.28 |
Support 1 (S1) | 26.97 | 27.05 | 26.83 | 26.95 | 26.60 |
Support 2 (S2) | 26.68 | 26.91 | 26.68 | 26.55 | |
Support 3 (S3) | 26.37 | 26.68 | 26.50 | ||
Support 4 (S4) | 26.35 |